Use of c-Src inhibitors in combination with a pyrimidylaminobenzamide compound for the treatment of leukemia

Details for Australian Patent Application No. 2012203659 (hide)

Owner Novartis AG

Inventors Manley, Paul W.

Agent Davies Collison Cave

Pub. Number AU-A-2012203659

Parent 2011202950

Filing date 22 June 2012

Wipo publication date 12 July 2012

International Classifications

A61K 31/4709 - Non-condensed quinolines containing further heterocyclic rings

A61K 31/506 - not condensed and containing further heterocyclic rings

A61K 31/519 - ortho- or peri-condensed with heterocyclic rings

A61P 35/02 Antineoplastic agents

Event Publications

12 July 2012 Application Open to Public Inspection

  Published as AU-A-2012203659

12 July 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203660-Non-irritating compositions containing zinc salts

2012203658-Complexes comprising angiostatin and its fragments, preparation preparing methods and uses thereof